Jim Cramer says these market rotations are crushing good stocks that don't deserve it.
These companies will do well, despite a range bound sector.
What you need to know.
Jim Cramer warns that development stage biotechs are for speculation only.
©1996-2017 TheStreet, Inc. All rights reserved.Action Alerts PLUS is a registered trademark of TheStreet, Inc.